Pemetrexed Fresenius Kabi – Pemetrexed uses, dose and side effects

}

25 mg / ml concentrate for solution for infusion
pemetrexed

What Pemetrexed Fresenius Kabi is and what it is used for

Pemetrexed Fresenius Kabi is a medicine used to treat cancer.

Pemetrexed Fresenius Kabi is co-administered with cisplatin, another anti-cancer drug, for the treatment of malignant pleural mesothelioma, a form of lung sac cancer, in patients who have not previously received anti-cancer drug therapy.

Pemetrexed Fresenius Kabi is also used with cisplatin in the initial treatment of advanced lung cancer.

Pemetrexed Fresenius Kabi can be prescribed to you if you have advanced lung cancer and your disease has responded to treatment or if it is largely unchanged after initial drug treatment.

In addition, Pemetrexed Fresenius Kabi is used to treat advanced lung cancer whose disease has progressed, after other previous drug treatments have been used.

What you need to know before using Pemetrexed Fresenius Kabi

Do not use Pemetrexed Fresenius Kabi

  • if you are allergic to pemetrexed or any of the other ingredients of this medicine (listed in section 6).
  • if you are breastfeeding, you should stop breastfeeding during treatment with Pemetrexed Fresenius Kabi.
  • if you have recently been vaccinated or are just about to be vaccinated against yellow fever.

Warnings and cautions

Talk to your doctor or pharmacist before receiving Pemetrexed Fresenius Kabi.

Talk to your doctor or pharmacist if you have or have had kidney problems, as you may not be able to get Pemetrexed Fresenius Kabi.

Before each infusion, blood samples will be taken to determine if the function of the kidneys and liver is sufficient and to check that the amount of blood cells is sufficient to obtain Pemetrexed Fresenius Kabi. Your doctor may choose to change the dose or postpone your treatment depending on your general condition and if your blood levels are too low. If you are also taking cisplatin, your doctor will make sure that you have been given enough fluids and that you will receive appropriate treatment before and after the cisplatin treatment to prevent vomiting.

If you have received radiation therapy or if such treatment is planned, tell your doctor, like radiation therapy and Pemetrexed Fresenius Kabi may cause immediate or late side effects.

If you have recently been vaccinated, you should tell your doctor, as Pemetrexed Fresenius Kabi in connection with vaccination may cause unwanted reactions.

Tell your doctor if you have, or have previously had, heart disease.

If you have fluid accumulation around your lungs, your doctor may decide to remove the fluid before treatment with Pemetrexed Fresenius Kabi.

Children and young people

This medicine should not be used by children or adolescents as there is no experience with the medicine in children and adolescents under 18 years of age.

Other medicines and Pemetrexed Fresenius Kabi

Tell your doctor if you are taking, have recently taken, or might take any medicine for pain or inflammation (swelling), such as so-called non-steroidal anti-inflammatory drugs ( NSAIDs ), including over-the-counter medicines (such as ibuprofen ). There are many different types of these drugs with varying duration of action. With the knowledge of the date of the planned infusion of Pemetrexed Fresenius Kabi and/or renal function status, your doctor must advise you on which medicines you can take and when you can take them. If you are not sure, ask your doctor or pharmacist if any of your medicines are NSAIDs.

Tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.

Pregnancy, breastfeeding, and fertility

Pregnancy 

If you are pregnant, think you may be pregnant, or are planning to have a baby, tell your doctor. Treatment with Pemetrexed Fresenius Kabi should be avoided during pregnancy. Your doctor will discuss any possible risks when Pemetrexed Fresenius Kabi is given during pregnancy. Women should use effective contraception during treatment with Pemetrexed Fresenius Kabi.

Breast-feeding 

Tell your doctor if you are breastfeeding.

Breast-feeding should be discontinued during treatment with Pemetrexed Fresenius Kabi.

Fertility

Men are advised not to have children during and up to 6 months after treatment with Pemetrexed Fresenius Kabi and should therefore use an effective method of contraception during treatment with Pemetrexed Fresenius Kabi and for up to 6 months after stopping treatment. If you plan to have children during treatment or the following 6 months after treatment, consult your doctor or pharmacist. You may want to seek advice on sperm preservation before starting treatment.

Driving and using machines

Treatment with Pemetrexed Fresenius Kabi may make you feel tired. Be careful when driving or using machines.

Pemetrexed Fresenius Kabi contains 964 mg hydroxypropylbetadex per 100 mg pemetrexed.

If you have any kidney disease, talk to your doctor before using this medicine.

How to use Pemetrexed Fresenius Kabi

Pemetrexed Fresenius Kabi is given in a dose of 500 mg per square meter of body surface area. Your height and weight are used to calculate the body surface area. Your doctor will use the measurement of your body surface area to calculate the correct dose for you. This dose can be adjusted or the treatment can be postponed depending on blood levels and your general condition. A hospital pharmacist, nurse, or doctor will have mixed Pemetrexed Fresenius Kabi with sodium chloride 9 mg/ml (0.9%) solution for injection or 5% glucose intravenous infusion solution before it is given to you.

Pemetrexed Fresenius Kabi is always given as an infusion to a friend. Infusion one lasts for about 10 minutes.

When Pemetrexed Fresenius Kabi is given in combination with cisplatin:

Your doctor or hospital pharmacist will have calculated the required dose using your height and weight. Cisplatin is also given as an infusion into a vein and it is given about 30 minutes after infusion one of the Pemetrexed Fresenius Kabi is ready. Infusion one of cisplatin lasts for about 2 hours.

You usually receive an infusion once every three weeks.

Other medicines:

Corticosteroids: Your doctor will prescribe steroid tablets (equivalent to 4 milligrams of dexamethasone twice daily). You should take these tablets the day before, on the day of treatment, and the day after treatment with Pemetrexed Fresenius Kabi. The tablets are given to reduce the frequency and severity of the skin reactions that may occur during cancer treatment.

Vitamin supplement: Your doctor will prescribe a preparation of folic acid ( vitamin ) to be taken by mouth or a multivitamin preparation containing folic acid (350 to 1000 micrograms) that you should take once a day during treatment with Pemetrexed Fresenius Kabi. You should take at least 5 doses during the seven days preceding the first dose of one of Pemetrexed Fresenius Kabi. You should continue to take folic acid for 21 days after the last Pemetrexed Fresenius Kabidos. You will also receive a vitamin B 12 injection of 1000 micrograms) the week before Pemetrexed Fresenius Kabi- infusion one and then approximately every 9 weeks (equivalent to 3 courses of treatment with Pemetrexed Fresenius Kabi). Vitamin B 12 and folic acid are given to reduce the possible harmful effects of cancer treatment.

If you have any further questions on the use of this product, ask your doctor or pharmacist.

Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

You should contact your doctor immediately if you notice any of the following side effects:

  • Fever or infection (common): if you have a temperature of 38 ° C or more, sweating, or other signs of an infection (because you may have lower than normal white blood cell count, which is very common). Infection one (blood poisoning) can be serious and lead to death.
  • If you start to feel chest pain (common) or have a fast heart rate (less common).
  • If you feel pain, redness, swelling, or soreness in your mouth (very common).
  • Allergic reaction: if you get a rash (very common) / burning or stinging sensation (common) or fever (common). Skin reactions can be serious and lead to death (rare). Contact your doctor if you get a lot of rash, itching, or blisters ( Stevens-Johnson syndrome or toxic epidermal necrolysis ).
  • If you get tired, feel weak, get short of breath easily, or if you look pale (because you may have less hemoglobin than normal, which is very common).
  • If it bleeds from the gums, nose, or mouth or you get any bleeding that does not want to stop, reddish or pinkish urine, unexpected bruising (because you may have fewer platelets than normal, which is very common).
  • If you experience sudden shortness of breath, intense chest pain, or cough with bloody cough (less common) (may indicate a blockage in the blood vessels of the lungs)

Other side effects of pemetrexed may occur:

Very common (may affect more than 1 user in 10)

Infection

Sore throat

Low neutrophil count ( white blood cell type )

Low white blood cell count

Low hemoglobin ( anemia )

Pain, redness, swelling, or soreness in the mouth

Decreased appetite

Vomiting

Diarrhea

Nausea

Rash

Flaking skin

Abnormal blood counts showing reduced kidney function

Fatigue (fatigue)

Common (may affect up to 1 in 10 people)

Blood infection

Fever with low neutrophil count ( white blood cell type )

Reduced platelet count

Allergic reaction

Dehydration

Taste changes

Muscle weakness due to damage to motor nerves, especially in the arms and legs

Loss of sensation, burning pain, and unsteady gait due to damage to sensory nerves

Dizziness

Inflammation or swelling of the conjunctiva ( membrane at the end of the eyelids and covering the eyes white)

Dry eyes

Tear-filled eyes

Dried conjunctiva ( membrane on the outer part of the eyelids and covering the eyes white and cornea (the clear layer that protects the iris and pupil )

Swollen eyelids

Eye problems, such as dryness, tearing, irritation, and/or pain.

Heart failure (a condition that affects the pumping power of your heart muscle)

Irregular heartbeat

Indigestion

Constipation

Abdominal pain

Liver: increase in the substances in the blood produced by the liver

Increased skin pigmentation

Itching

Rash on the body therewith red marks

Hair loss

Hives

Kidney failure

Decreased renal function

Fever

Pain

Excess fluid in body tissue, which causes swelling

Chest pain

Inflammation and ulceration of the mucous membranes that line the digestive tract

Uncommon (may affect up to 1 in 100 people)

Reduction in the number of red and white blood cells and platelets

Stroke

Type of stroke when an artery to the brain is blocked

Bleeding inside the skull

Angina (Chest pain caused by decreased blood flow to the heart)

Myocardial infarction

Narrowing or blockage of the coronary arteries

Faster heart rate

Reduced blood distribution to the limbs

Blood clots in the pulmonary blood vessels ( pulmonary embolism )

Inflammation and scarring of the lungs with respiratory problems

Passage of bright red blood from the anus

Bleeding in the gastrointestinal tract

Broken intestine

Inflammation of the esophageal mucosa (esophagus)

Colitis ( inflammation of the wall of the colon, which may be accompanied by bleeding from the intestines or rectum (seen only in combination with cisplatin)

Inflammation, edema , erythema, and erosion of the mucosal surface of the esophagus caused by radiation therapy

Inflammation of the lung caused by radiation therapy

Rare (may affect up to 1 in 1,000 people)

Destruction of red blood cells

Anaphylactic shock (severe allergic reaction )

Inflammatory conditions of the liver

Redness of the skin

Skin rash that may occur on skin that has previously been exposed to radiation therapy.

Very rare (may affect up to 1 in 10,000 people)

Infection of skin and soft tissue

Stevens-Johnson syndrome (a type of severe reaction to skin and mucous membranes that can be life-threatening)

Toxic epidermal necrolysis (a type of severe skin reaction that can be life-threatening)

An autoimmune condition that results in skin rashes and blisters on legs, arms, and abdomen

Inflammation of the skin characterized by the presence of bullous conditions with fluid-filled blistering)

Fragile skin, blisters, and erosion as well as scarring of the skin

Redness, pain, and swelling mainly in the lower legs

Inflammation of the skin and fat under the skin (pseudocellulitis)

Inflammation of the skin ( dermatitis )

Skin that becomes inflamed, itchy, red, cracked, and rough

Intense itchy spots

Has been reported (occurs in an unknown number of users)

A form of diabetes that is primarily based on kidney pathology

Kidney disorder involving tubular epithelial cells (which form renal tubules) death

You may get any of these symptoms and/or ailments. If you start to experience any of these side effects, talk to your doctor as soon as possible.

If you have any side effects, talk to your doctor.

How to store Pemetrexed Fresenius Kabi

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the vial label and the carton after “EXP. that ”. The expiration date is the last day of the specified month.

Do not store above 25 ° C.

Keep the vial in the outer carton. Sensitive to light.

Infusion solution: The medicine should be used immediately. If the preparation instructions are followed, chemical and physical durability has been demonstrated for 21 days in the refrigerator and 7 days in

25 ° C for diluted pemetrexed infusion solution.

The solution should not be used if it contains particles.

This medicine is for single use only.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.

Contents of the pack and other information

Content declaration

The active substance is pemetrexed.

One ml of concentrate contains 25 mg of pemetrexed.

After dilution, a vial of 4 ml concentrate contains 100 mg of pemetrexed (as pemetrexed acid).

After dilution, a vial of 20 ml concentrate contains 500 mg of pemetrexed (as pemetrexed acid).

After dilution, a vial of 40 ml concentrate contains 1000 mg of pemetrexed (as pemetrexed acid).

The other ingredients are hydroxypropyl betadex, hydrochloric acid, trometamol, and water for injections.

What the medicine looks like and the contents of the pack

Pemetrexed Fresenius Kabi is a concentrate for solution for infusion (sterile concentrate) packaged in a glass vial. It is colorless to the slightly yellowish or greenish-yellow solution.

Available in packs of 1 vial.

Marketing Authorization Holder and Manufacturer

Marketing Authorisation Holder

Fresenius Kabi Deutschland GmbH

Else ‑ Kröner ‑ Straße 1.61352 Bad Homburg vdHöhe

Germany

Manufacturer

Fresenius Kabi Deutschland GmbH

Pfingstweide 53 61169 Friedberg

Germany

Or

Fresenius Kabi Polska Sp. z oo

ul. Sienkiewicza 25, Kutno, 99-300, Poland

Leave a Reply